Fred Logan has been named director of elementary education at Spartanburg School District 7. Logan will work with the newly appointed associate superintendent for school leadership, curriculum and instruction, Terry Pruitt. After graduating from Spartanburg High School, Logan received a bachelor of arts and a masters in education. He also holds an
March 19, 2008 – San Jose, CA This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-eight (38) new catalog peptides.
Four Limestone College biology majors recently presented the results of their undergraduate research projects at the annual South Carolina Independent Colleges and Universities (SCICU) Student/Faculty Undergraduate Research Symposium at the BMW Zentrum Center in Greer.
Goldfish are able to dash after food flakes at mealtime, reaching them before they sink or are eaten by other fish. Researchers recently proved in lab experiments that marine bacteria behave in a similar fashion at mealtime, using their swimming skills to reach tiny food patches that appear randomly in the ocean blue. This behavior at small scales could have global implications for the oceans'
Goldfish in an aquarium are able to dash after food flakes at mealtime, reaching them before they sink or are eaten by other fish. Researchers at MIT recently proved that marine bacteria, the smallest creatures in the ocean, behave in a similar fashion at mealtime, using their swimming skills to reach tiny food patches that appear randomly in the ocean blue.
Ception Therapeutics, Inc. announced the initiation of a multi-center, Phase II/III clinical trial to evaluate reslizumab, a humanized monoclonal antibody (mAb) against interleukin-5 (IL-5), for the treatment of eosinophilic esophagitis (EE) in pediatric patients.
MALVERN, Pa. ( Map ) - MALVERN, Pa., March 5 /PRNewswire/ -- Ception Therapeutics, Inc. announced today the initiation of a multi-center, Phase II/III clinical trial to evaluate reslizumab, a humanized monoclonal antibody (mAb) against interleukin-5 (IL-5), for the treatment of eosinophilic esophagitis (EE) in pediatric patients.